Nunes-Xavier CE(2024) Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer Transl Oncol, 47, 102005 DOI 10.1016/j.tranon.2024.102005, PubMed 39034056
Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K(2024) Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer J Transl Med, 22(1), 646 DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Ree AH, Høye E, Esbensen Y, Beitnes AR, Negård A, Bernklev L, Tetlie LK, Fretland ÅA, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Nilsen HL, Flatmark K, Meltzer S(2024) Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade Oncoimmunology, 13(1), 2372886 DOI 10.1080/2162402X.2024.2372886, PubMed 38952672